Acquisition Completed
Isto Biologics acquisition of NovaBone Products
US$60m consideration
Announced Aug 2026 (approx.)
Advisers
NovaBone Products
Target
Not disclosed
- Target
- NovaBone Products
- Acquirer
- Isto Biologics
- Seller
- Halma
- Target based in
- United States
- Buyer based in
- United States
- Seller based in
- United Kingdom
- Completed
- 5 Aug 2026
- Sector
- Medtech
- Tags
- Medtech, Life Sciences
In the league tables
Similar deals
- Nordic Capital acquisition of BWXT Medical business Aug 2026 · US$800m · Radiopharmaceuticals
- Thelema S.à r.l. acquisition of B Medical Systems Jul 2026 · Medtech
- Cinven stake in Regenity Biosciences May 2026 · Medtech
- Telix Pharmaceuticals acquisition of ImaginAb therapeutic candidates, biologics technology platform and research facility Jan 2025 · US$45m · Healthcare
- Zimmer Biomet Holdings acquisition of Pacira's iovera° business Jun 2026 · US$70m · Medtech
Sources
- 5 Aug 2026 Baird: Baird served as exclusive financial advisor to Isto on this transaction. rwbaird.com